About Fangzhou Jianke
Fangzhou Jianke is a publicly listed company based in Haidian (China) founded in 2009. An online pharmacy platform is operated for medicine sales. It operates on a Direct-to-Consumer (D2C) and On-Demand Services model. Fangzhou Jianke has raised $280 million across 4 funding rounds from investors including Crescent Point, Hbm and ShenZhen GTJA Investment Group. The company has 488 employees. Its website jianke.com draws about 124 thousand monthly visits. Fangzhou Jianke offers products and services including Online Pharmacy and Health Consultation. Its focus areas include Pharmaceuticals and Online Pharmacy. Its competitors include 111 Group, Shanghai Pharmaceutical and 7LK; 3 of its 3 listed competitors have raised funding.
Company details
Fangzhou Jianke is recognized as a legitimate online pharmacy certified by the National Medical Products Administration in China. A wide range of pharmaceutical products and healthcare items are offered through the platform. Various health conditions including mens health, cardiovascular issues, diabetes, and dermatology are addressed with relevant medications. Health consultation services are provided to assist customers with professional advice. The platform is committed to delivering affordable, high-quality, and convenient healthcare solutions. A trusted smart health service platform is aimed to be established for users across China.
- Headquarters Haidian, China
- Employees 488
- Stage Public
- SectorsHealthcare
- Website category Health
- Phone•••• ••••
- Website jianke.com
- Social LinkedIn X
- Legal Name Fangzhou Inc.
- Annual Revenue$490.74 M (USD)30.28as on Dec 31, 2025
- Net Profit$1.65 M (USD)as on Dec 31, 2025
- EBITDA$4.22 M (USD)as on Dec 31, 2025
- Total Equity Funding$280M (USD)
in 4 rounds
- Latest Funding Round$19.24M (USD), Post-IPO
Jan 2026
- InvestorsCrescent Point
& 4 more
- Employee Count488
Products & Services of Fangzhou Jianke
Fangzhou Jianke offers a comprehensive portfolio of products and services, including Online Pharmacy and Health Consultation.
Medicines are sold through an online platform.
Health advice is provided by professional pharmacists.
Funding Insights of Fangzhou Jianke
Fangzhou Jianke has successfully raised a total of $280M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $19.24 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $280M
- Total Rounds 4
- Last Round Post-IPO — $19.24M
- First Round $100M
(Jan 2016)
- Investors Count 5
All 4 funding rounds of Fangzhou Jianke with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2026 | $19.24M | Post-IPO | – | – | – |
| Sep 2018 | $130M | Series B | – | ShenZhen GTJA Investment Group | |
| May 2017 | $50M | Series B | – | Volcanics Venture, PGA Venture Partners | – |
| Jan 2016 | $100M | Series A | – | Crescent Point | – |
5 investors in total: 5 institutional.
Investors in Fangzhou Jianke
Fangzhou Jianke has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Crescent Point, Hbm and ShenZhen GTJA Investment Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth equity is provided to consumer-focused companies by Crescent Point. | 2001 | cgcm.com | Singapore, Singapore | |
| szgig.com | ||||
Investment services are offered by Volcanics to clients. | volcanics.com | |||
| pgagc.com | ||||
Sensors for strain, force, torque, and load measurement are developed. | 1950 | hbm.com | Darmstadt, Germany |
Investor details for Fangzhou Jianke
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
IPO & Listings of Fangzhou Jianke
Fangzhou Jianke is a publicly listed company on the HKEX with ticker symbol 6086 in Hong Kong, operating in the Retail trade sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date09 Jul 2024
- Listed onHKG: 6086
- Listed entityFangzhou Inc.
- Exchange sectorRetail trade
- ISINKYG3314S1066
- Share price0.82 HKD (-1.2% on the day) · 2026-10-14
- Market capitalisation1,156,849,456.00 HKD
- Price to earnings119.6
- EPS (diluted, trailing year)0.01 HKD
- Volume (last session)331,500
Financials of Fangzhou Jianke
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 3.82B HKD | 12.8M HKD | 32.9M HKD |
| 2024 | 2.94B HKD | -926.9M HKD | -786.6M HKD |
| 2023 | 2.69B HKD | -217.4M HKD | -8.5M HKD |
| 2022 | 2.56B HKD | -445.7M HKD | -127.8M HKD |
| 2021 | 2.12B HKD | -366.3M HKD | -260.1M HKD |
Detailed financial statements for Fangzhou Jianke
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Fangzhou Jianke
4 dated milestones of Fangzhou Jianke across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Fangzhou Jianke is founded.
- Funding First funding round of $100.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $19.2M.
Competitors of Fangzhou Jianke
Fangzhou Jianke has 3 listed competitors in our database, 3 of them funded. They include 111 Group, Shanghai Pharmaceutical and 7LK.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 111.com.cn | 2010 | Guangzhou, China | $122M | Online pharmacy for selling pharmaceuticals and health products | ||
| sphcchina.com | 2015 | Shanghai, China | $228.18M | Provider of a cloud-based mobile app for purchasing medicines online | ||
| 7lk.com | 2011 | Guangzhou, China | $48M | Non-prescription drugs and health supplements are retailed online by 7LK. |
Detailed competitors of Fangzhou Jianke
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Fangzhou Jianke
The website of Fangzhou Jianke (jianke.com) receives about 123.9K visits a month and ranks #271,461 among all websites worldwide, #9,245 in Health.
- Monthly visits123.9K
▼ 28.1% vs previous month
- Unique visitors94.7K
per month
- Global rank#271,461
among all websites
- Category rank#9,245
Health · Health
- Bounce rate47%
- Pages per visit1.7
- Average visit37 sec
- DevicesDesktop 26% · Mobile 74%
Websites whose visitors overlap most with Fangzhou Jianke. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
800pharm.com | 800pharm.com | 100% | – | ||
360kxr.com | 360kxr.com | 99% | – | ||
| ehaoyao.com | 95% | View details | |||
yaofangwang.com | yaofangwang.com | 94% | #582,026 | – | |
315jiage.cn | 315jiage.cn | 93% | #330,371 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Fangzhou Jianke
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fangzhou Jianke
Complete news archive for Fangzhou Jianke
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fangzhou Jianke
Fangzhou Jianke was founded in 2009 and raised its 1st funding round 7 years after it was founded.
Fangzhou Jianke is headquartered in Haidian, China. It is registered at Haidian, Beijing, China.
Fangzhou Jianke is a funded company, having raised a total of $280M across 4 funding rounds to date. The company's 1st funding round was a Series A of $100M, raised on Jan 2016.
Fangzhou Jianke has 488 employees.
Annual revenue of Fangzhou Jianke is $490.74M as on Dec 31, 2025.
Fangzhou Jianke is recognized as a legitimate online pharmacy certified by the National Medical Products Administration in China. A wide range of pharmaceutical products and healthcare items are offered through the platform. Various health conditions including mens health, cardiovascular issues, diabetes, and dermatology are addressed with relevant medications. Health consultation services are provided to assist customers with professional advice. The platform is committed to delivering affordable, high-quality, and convenient healthcare solutions. A trusted smart health service platform is aimed to be established for users across China.
Fangzhou Jianke's top competitors include 111 Group, Shanghai Pharmaceutical and 7LK.
Fangzhou Jianke offers Online Pharmacy and Health Consultation.
Yes, Fangzhou Jianke is publicly traded on HKEX under the ticker symbol 6086.
Fangzhou Jianke has 5 investors. Key investors include Crescent Point, Hbm, ShenZhen GTJA Investment Group, Volcanics, and PGA Venture Partners.
The website of Fangzhou Jianke receives about 124 thousand visits a month and ranks #271,461 among all websites worldwide.